期刊介绍
JMCP welcomes research studies conducted outside of the United States that are relevant to our readership. Our audience is primarily concerned with designing policies of formulary coverage, health benefit design, and pharmaceutical programs that are based on evidence from large populations of people. Studies of pharmacist interventions conducted outside the United States that have already been extensively studied within the United States and studies of small sample sizes in non-managed care environments outside of the United States (e.g., hospitals or community pharmacies) are generally of low interest to our readership. However, studies of health outcomes and costs assessed in large populations that provide evidence for formulary coverage, health benefit design, and pharmaceutical programs are of high interest to JMCP’s readership.
投稿要求
CITESCORE
| CiteScore | SJR | SNIP | CiteScore排名 |
|---|
| 4.10 | 1.020 | 0.948 | | 学科 | 分区 | 排名 | 百分位 | 大类:Health Professions 小类:Pharmacy | Q1 | 4 / 47 |
| 大类:Health Professions 小类:Health Policy | Q2 | 107 / 320 |
| 大类:Health Professions 小类:Pharmaceutical Science | Q2 | 83 / 185 |
|
|
WOS期刊JCR分区
WOS分区等级:
2区| 按JIF指标学科分区 | 收录子集 | JIF分区 | JIF排名 | JIF百分位 |
| 学科:HEALTH CARE SCIENCES & SERVICES | SCIE | Q2 | 60/185 |
|
| 学科:PHARMACOLOGY & PHARMACY | SCIE | Q2 | 150/352 |
|
| 按JCI指标学科分区 | 收录子集 | JCI分区 | JCI排名 | JCI百分位 |
| 学科:HEALTH CARE SCIENCES & SERVICES | SCIE | Q2 | 77/185 |
|
| 学科:PHARMACOLOGY & PHARMACY | SCIE | Q2 | 119/353 |
|
期刊分区表预警名单
2025年03月发布的2025版:不在预警名单中
2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
中科院2025年3月升级版
点击查看中国科学院期刊分区趋势图| 大类学科 | 小类学科 | Top期刊 | 综述期刊 |
|---|
| 医学 2区4区2区 | HEALTH CARE SCIENCES & SERVICES 卫生保健与服务 | 2区4区4区 | PHARMACOLOGY & PHARMACY 药学 | 4区2区4区 |
| 否 | 否 |
中科院2023年12月旧的升级版
| 大类学科 | 小类学科 | Top期刊 | 综述期刊 |
|---|
| 医学 1区4区2区 | HEALTH CARE SCIENCES & SERVICES 卫生保健与服务 | 1区1区4区 | PHARMACOLOGY & PHARMACY 药学 | 4区1区4区 |
| 否 | 否 |